- Director, Vascular Center, Harrington Heart and Vascular Institute, University Hospitals
- Division Chief, Vascular Surgery, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Aortic Pathologies
- Cerebrovascular Disease
- Endovascular Therapies
- Peripheral Occlusive Disease
- Surgical Revascularization
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (10)
Reviewed On 5/1/2020
Dr. Kashyup has always been polite and thorough.
Reviewed On 3/4/2020
this doctor is very kind and caring person.
Reviewed On 2/4/2020
Dr. and stafff are excellent.
Reviewed On 1/2/2020
the doctor was very thorough and explained everything [...] I have to go back in six months wonderful man and explained everything, his staff was just as courteous and kind as he feel very confident with him
Reviewed On 12/2/2019
Very knowledgeable and concerned for my well being
Reviewed On 10/1/2019
I was totally impressed with the doctors knowledge, manner and kindness. he made me feel totally at ease.
Reviewed On 9/3/2019
very good doctor I would recommend him to anyone.
Reviewed On 8/22/2019
Provider was very knowledgeable and took extra time with me to answer all my questions. I am very pleased
Reviewed On 8/2/2019
Dr. Kashyap is not only an excellent surgeon who saved my life three years ago, but he's an excellent human. He's compassionate and empathic and I couldn't have asked for a more quality individual to be a part of my healthcare!
Reviewed On 7/19/2019
Very good coordination and care. the doctor is very, very good. he explains everything. glad to have him in charge of my aneurism.
- Vascular Surgery - American Board of Surgery
Fellowship | Vascular Surgery
Vascular Surgery - University Of California, Los Angeles David Geffen School Of Medicine (1997 - 1999)
Research Fellowship | General Surgery
General Surgery - National Institutes Of Health (1993 - 1995)
Residency | General Surgery
General Surgery - Massachusetts General Hospital (1990 - 1997)
Jefferson Medical College Of Thomas Jefferson University (1990)
Pennsylvania State University (1986)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Vikram Kashyap did not disclose any Outside Relationships with Industry.